CHONG KUN DANG PHARMACEUTICAL CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103,600 KRW | +0.48% |
|
-0.67% | -20.86% |
ETFs positioned on Chong Kun Dang Pharmaceutical Corp.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 0 M€ | +4.12% | - | |
| 0.00% | 0 M€ | +3.22% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 0 M€ | +3.45% | - |
Chong Kun Dang Pharmaceutical Corp is a Korea-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The company sells products in domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -20.86% | 969M | |
| +20.83% | 43.57B | |
| +20.70% | 22.7B | |
| +16.41% | 14.32B | |
| +11.11% | 13.42B | |
| +45.91% | 11.83B | |
| -8.84% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.41% | 5.51B |
- Stock Market
- Equities
- A185750 Stock
- Funds and ETFs Chong Kun Dang Pharmaceutical Corp.